News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
175,191 Results
Type
Article (12901)
Company Profile (23)
Press Release (162267)
Multimedia
Podcasts (10)
Webinars (5)
Section
Business (48474)
Career Advice (611)
Deals (9076)
Drug Delivery (30)
Drug Development (27948)
Employer Resources (69)
FDA (4668)
Job Trends (3850)
News (90771)
Policy (7809)
Tag
Academia (1072)
Academic (1)
Accelerated approval (1)
Adcomms (6)
Allergies (34)
Alliances (13647)
ALS (37)
Alzheimer's disease (433)
Antibody-drug conjugate (ADC) (22)
Approvals (4680)
Artificial intelligence (63)
Autoimmune disease (8)
Automation (3)
Bankruptcy (70)
Best Places to Work (3200)
BIOSECURE Act (6)
Biosimilars (34)
Biotechnology (11)
Bladder cancer (25)
Brain cancer (8)
Breast cancer (81)
Cancer (594)
Cardiovascular disease (63)
Career advice (514)
Career pathing (13)
CAR-T (45)
Cell therapy (109)
Cervical cancer (9)
Clinical research (23797)
Collaboration (176)
Compensation (15)
Complete response letters (1)
COVID-19 (1084)
CRISPR (8)
C-suite (56)
Cystic fibrosis (20)
Data (747)
Denatured (7)
Depression (9)
Diabetes (97)
Diagnostics (1701)
Digital health (3)
Diversity (5)
Diversity, equity & inclusion (28)
Drug discovery (38)
Drug pricing (39)
Drug shortages (16)
Duchenne muscular dystrophy (32)
Earnings (14286)
Editorial (17)
Employer branding (5)
Employer resources (63)
Events (20873)
Executive appointments (187)
FDA (5002)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (200)
Gene editing (17)
Generative AI (6)
Gene therapy (85)
GLP-1 (268)
Government (1179)
Grass and pollen (2)
Guidances (11)
Healthcare (5374)
Huntington's disease (6)
IgA nephropathy (9)
Immunology and inflammation (32)
Indications (6)
Infectious disease (1129)
Inflammatory bowel disease (53)
Inflation Reduction Act (4)
Influenza (15)
Intellectual property (17)
Interviews (104)
IPO (3431)
IRA (19)
Job creations (772)
Job search strategy (450)
Kidney cancer (2)
Labor market (7)
Layoffs (79)
Leadership (9)
Legal (1523)
Liver cancer (21)
Lung cancer (69)
Lymphoma (42)
Machine learning (2)
Management (22)
Manufacturing (68)
MASH (33)
Medical device (3164)
Medtech (3166)
Mergers & acquisitions (5793)
Metabolic disorders (218)
Multiple sclerosis (40)
NASH (15)
Neurodegenerative disease (22)
Neuropsychiatric disorders (4)
Neuroscience (617)
NextGen: Class of 2025 (1994)
Non-profit (1633)
Obesity (99)
Opinion (47)
Ovarian cancer (15)
Pain (32)
Pancreatic cancer (21)
Parkinson's disease (54)
Partnered (7)
Patents (29)
Patient recruitment (37)
Peanut (17)
People (17268)
Pharmaceutical (11)
Pharmacy benefit managers (9)
Phase I (5269)
Phase II (10230)
Phase III (9708)
Pipeline (298)
Policy (55)
Postmarket research (1147)
Preclinical (1915)
Press Release (29)
Prostate cancer (37)
Psychedelics (9)
Radiopharmaceuticals (63)
Rare diseases (107)
Real estate (1372)
Recruiting (23)
Regulatory (5737)
Reports (13)
Research institute (894)
Resumes & cover letters (82)
Rett syndrome (1)
RSV (18)
Schizophrenia (24)
Series A (47)
Series B (30)
Service/supplier (2)
Sickle cell disease (12)
Special edition (2)
Spinal muscular atrophy (62)
Sponsored (5)
Startups (1178)
Stomach cancer (4)
Supply chain (15)
Tariffs (8)
The Weekly (3)
Vaccines (280)
Venture capitalists (8)
Weight loss (69)
Women's health (15)
Worklife (7)
Date
Today (36)
Last 7 days (184)
Last 30 days (570)
Last 365 days (7960)
2025 (2554)
2024 (8411)
2023 (9580)
2022 (12871)
2021 (14465)
2020 (14040)
2019 (13513)
2018 (10431)
2017 (9480)
2016 (9131)
2015 (10801)
2014 (7356)
2013 (5763)
2012 (6225)
2011 (6605)
2010 (5694)
Location
Africa (252)
Alabama (7)
Alaska (4)
Arizona (41)
Arkansas (2)
Asia (12487)
Australia (2400)
California (1233)
Canada (382)
China (148)
Colorado (51)
Connecticut (49)
Delaware (39)
Europe (33277)
Florida (172)
Georgia (72)
Idaho (14)
Illinois (146)
India (10)
Indiana (86)
Iowa (2)
Japan (69)
Kansas (30)
Kentucky (7)
Louisiana (6)
Maine (11)
Maryland (217)
Massachusetts (821)
Michigan (38)
Minnesota (86)
Missouri (18)
Montana (6)
Nebraska (6)
Nevada (18)
New Hampshire (10)
New Jersey (446)
New Mexico (7)
New York (483)
North Carolina (174)
Northern California (527)
Ohio (39)
Oklahoma (3)
Oregon (4)
Pennsylvania (302)
Puerto Rico (3)
Rhode Island (4)
South America (374)
South Carolina (8)
Southern California (497)
Tennessee (17)
Texas (153)
United States (4896)
Utah (21)
Virginia (26)
Washington D.C. (7)
Washington State (159)
Wisconsin (11)
175,191 Results for "emmes group".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Emmes Group® names Germaine Gross Chief Commercial Officer of Emmes® Biopharma
January 16, 2025
·
3 min read
Drug Development
ILiAD Biotechnologies Announces Planned Collaboration with Emmes Group, a New Mountain Capital Portfolio Company, to Conduct Upcoming Phase III Clinical Trials of BPZE1, the Leading Next-Generation Pertussis Vaccine
ILiAD Biotechnologies, LLC today announced the selection of Emmes Group, a global contract research and technology organization, to conduct upcoming Phase III studies of its lead pertussis vaccine candidate, BPZE1. ILiAD and Emmes Group are currently working to finalize the definitive agreement.
June 24, 2024
·
4 min read
Press Releases
Duchesnay Pharmaceutical Group creates Advisory Board to help guide the Group’s growth and success
April 16, 2025
·
5 min read
Press Releases
Orion Group Interim Report January–March 2025
April 23, 2025
·
6 min read
Emmes Acquires VaxTRIALS
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation
October 5, 2023
·
3 min read
Press Releases
Sunflower Therapeutics Announces an Exclusive Sales Representation Agreement with Optimal Biotech Group
April 30, 2025
·
3 min read
Press Releases
Olon Group Strengthens Its Leadership in Bioproduction with Two Strategic Appointments in France
April 29, 2025
·
3 min read
Press Releases
Emmes awarded multi-task, IDIQ contract with $50M ceiling, to support NIDA’s clinical trials network
September 4, 2024
·
2 min read
Press Releases
Pharming Group to report first quarter 2025 financial results on May 8
April 24, 2025
·
1 min read
Press Releases
Devonian Health Group Reports Second Quarter 2025 Financial Results
April 15, 2025
·
6 min read
1 of 17,520
Next
